Market Overview

Prader-Willi Syndrome | A Drug Pipeline Analysis Report 2018 | Technavio

Share:

Technavio has announced their latest analysis report on drug pipeline
for Prader-Willi
syndrome
. The report includes a detailed analysis of the
pipeline molecules under investigation within the defined data
collection period to treat Prader-Willi syndrome.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20180802005900/en/

Technavio has published a new report on the drug development pipeline for Prader-Willi syndrome, inc ...

Technavio has published a new report on the drug development pipeline for Prader-Willi syndrome, including a detailed study of the pipeline molecules. (Graphic: Business Wire)

This report by Technavio
presents a detailed analysis of the market, including regulatory
framework, drug development strategies, recruitment strategies, and key
companies that are expected to play an essential role in the growth of
the market in the future.

This report is available at a USD 1,000 discount for a limited time
only:
View
market snapshot before purchasing

Prader-Willi syndrome: Market overview

Prader-Willi syndrome is a disorder that is caused due to loss of active
genes in a specific region of chromosome 15. The part of the brain that
controls feelings of fullness does not work properly for people who have
PWS. Fluorescence in situ hybridization (FISH) test identifies deleted
genes in the chromosomes of people with PWS. DNA methylation testing is
another preferred diagnostic method for PWS genetic testing. This
testing identifies abnormal, parent related imprinting in the region of
chromosome 15, which is responsible for the development of PWS.

According to a senior market research analyst at Technavio, "As per
the data published by the EMA based on the Committee for Orphan
Medicinal Products in October 2017, PWS affected approximately 0.4
people in 10,000 people in the EU."

Prader-Willi syndrome: Segmentation analysis

This pipeline analysis report segments the Prader-Willi syndrome market
based on therapies employed (monotherapy and combination therapy), RoA
(oral, subcutaneous, intranasal, and parenteral), therapeutic modality
(small molecule, peptide, lipid, and protein), targets (somatotropin
receptor, oxytocin receptor, and others), MoA (somatotropin receptor
agonist and oxytocin receptor agonist), geographical segmentation (US,
China, South Korea, Czech Republic, and Canada) and recruitment status
(completed, planned, and recruiting). It provides an in-depth analysis
of the prominent factors influencing the market, including drivers,
opportunities, trends, and industry-specific challenges.

Based on therapies employed, close to 87% of the molecules that are
being investigated for the treatment of Prader-Willi syndrome is
monotherapy. Monotherapy uses a single drug to treat a particular
disorder.

Looking for more information on this market? Request
a free sample report

Technavio's sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.

Some of the key topics covered in the report include:

Scope of the Report

Regulatory Framework

Drug Development Landscape

  • Drugs under development
  • Indications coverage

Drug Development Strategies

  • Therapies employed
  • RoA
  • Therapeutic modality
  • Geographical coverage

Recruitment Strategies

  • Recruitment status
  • Gender
  • Age

Key Companies

  • Type of players
  • Company overview

Discontinued or Dormant Molecules

About Technavio

Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio's comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team
at media@technavio.com.

View Comments and Join the Discussion!